Skip to main content
Clinical Trials/NCT05611775
NCT05611775RecruitingNot Applicable

Real-World Functional Activity in Adult Spinal Deformity Surgery

Mayo Clinic1 site in 1 country50 target enrollmentStarted: June 16, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
50
Locations
1
Primary Endpoint
Motion Analysis Lab - Change in function

Study Overview

Brief Summary

The purpose of this study is to measure functional activity and stability in spinal deformity patients utilizing motion analysis testing and accelerometers.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of degenerative thoracolumbar deformity
  • •Deformity correction surgery scheduled with either Dr. Elder or Dr. Fogelson, minimum 4-level fusion with fixation to the pelvis.

Exclusion Criteria

  • •° Unable to return to Mayo Clinic for follow-up evaluation

Arms & Interventions

Activity Monitor Assessment

Other

Subjects will be assessed in the Motion Analysis Laboratory at Mayo Clinic Rochester and have activity monitored in the free-living environment.

Intervention: Triaxial accelerometer (Device)

Outcomes

Primary Outcomes

Motion Analysis Lab - Change in function

Time Frame: Baseline, 6-12 weeks post-surgery, 1 year

Spatiotemporal measures including velocity, step/stride length, step width, single/double support times, and R/L temporal symmetriesm will be used to measure function.

Motion Analysis Lab - Change in gait

Time Frame: Baseline, 6-12 weeks post-surgery, 1 year

Gait will be measured by segmental and joint range of motion, peak kinetics during walking, and changes in deviation from normal bands using sensory processing measures.

Motion Analysis Lab - Change in trunk stability

Time Frame: Baseline, 6-12 weeks post-surgery, 1 year

Trunk stability will be measured by EMG frequency content and activation pattern during gait and postural sway.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Benjamin D. Elder

Principal Investigator

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials